New model offers a way to speed up drug discovery
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
By mapping the volumes of objects, rather than their surfaces, a new technique could yield solutions to computer graphics problems in animation and CAD.
A new way of machining microscale rotors from diamond crystal can enable ultrasensitive NMR devices for probing proteins and other materials.
With the new method, scientists can explore many cancer mutations whose roles are unknown, helping them develop new drugs that target those mutations.
The method could enable a rapid test to determine whether individuals are producing antibodies that help protect against Covid-19.
MIT’s Science Policy Initiative sends students and postdocs to Capitol Hill to advocate for continued and increased federal support for scientific research.
MIT engineers’ new technique analyzes the 3D organization of the genome at a resolution 100 times higher than before.
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
These tunable proteins could be used to create new materials with specific mechanical properties, like toughness or flexibility.
Neurons that form part of a memory circuit are among the first brain cells to show signs of neurodegeneration in Alzheimer’s disease.
The peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases.
A new analysis reveals how Staphylococcus aureus gains mutations that allow it to colonize eczema patches.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.